Navigation Links
Optimizing Key Opinion Leader Relationship Management for Success in the Pharmaceutical Sector

CHAPEL HILL, N.C., Dec. 9, 2011 /PRNewswire/ -- Thought leaders play a critical role throughout the development cycle of new pharmaceutical products. In the pre-clinical stage, they serve as technical experts, in Phase I, II and III they are the clinical trial leaders and from pre-launch through patent expiry they are peer influencers.

Clearly, success in the pharmaceutical sector is linked to an organization's ability to build, maintain and manage relationships with Key Opinion Leaders (KOL). Consequently, KOL relationship management has emerged as its own business discipline, a necessary and challenging component of brand promotion.

A study from Best Practices, LLC, Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management, examines how leading pharmaceutical companies approach KOL management. This report identifies the organizational structures, management strategies and tactics, and critical success factors associated with KOL management excellence. Pharmaceutical executives can use this benchmarking research to learn best practices in KOL management and discover how they can maximize KOL relationships to benefit their own products and therapies.

For instance, data from an online survey and executive interviews revealed that organizations need to develop reliable, strategic profiling and recruitment mechanisms that:

  • Distinguish between true influence and credentials
  • Segment KOLs by the traits required for a company's needs and strategy
  • Seek opportunities to identify the next generation of KOLs
  • Use new tools and vendors to improve efficiency

Key topics in this report include:

  • KOL Segmentation and Behavior Drivers
  • KOL Roles Over Product Lifecycle
  • KOL Management Models
  • Role of Medical Science Liaisons (MSLs) in Managing KOLs
  • Emerging Trends and Innovative Practices in KOL Management
  • Critical Success Factors in KOL Management
  • Most Difficult Challenges in KOL Management

This 43-page study is based on research and information provided by 59 pharmaceutical and medical device executives from 42 companies.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link:

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GP and INERCO Form Strategic Alliance to Assist Clients with Optimizing Fuel Costs and Decreasing Emissions
2. Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate
3. Optimizing the Use of Health Outcomes Data in the Marketplace
4. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
5. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
6. Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
7. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
8. Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel
9. Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
10. RadMD Offers Tips on Optimizing Clinical Trial Efficiency
11. European Medicines Agencys (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
Breaking Medicine Technology:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):